OTC Markets OTCPK - Delayed Quote USD

BioGaia AB (publ) (BGLAF)

9.58
0.00
(0.00%)
As of May 7 at 4:00:00 PM EDT. Market Open.
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,422,718
1,422,718
1,296,506
1,103,958
785,111
Cost of Revenue
391,975
391,975
346,316
302,028
202,161
Gross Profit
1,030,743
1,030,743
950,190
801,929
582,949
Operating Expense
607,372
607,372
507,087
467,262
340,352
Operating Income
423,371
423,371
443,103
334,667
242,597
Net Non Operating Interest Income Expense
24,448
24,448
25,731
2,577
-1,025
Pretax Income
447,819
447,819
468,834
447,613
252,712
Tax Provision
96,431
96,431
103,482
73,840
56,439
Net Income Common Stockholders
351,388
351,388
365,352
373,773
196,273
Diluted NI Available to Com Stockholders
351,388
351,388
365,352
373,773
196,273
Basic EPS
3.48
3.48
3.62
3.70
1.94
Diluted EPS
3.48
3.48
3.62
3.70
1.94
Basic Average Shares
101,072
101,072
100,982
100,982
100,982
Diluted Average Shares
101,072
101,072
100,982
100,982
100,982
Total Operating Income as Reported
423,371
423,371
443,103
361,459
253,737
Total Expenses
999,347
999,347
853,403
769,290
542,513
Net Income from Continuing & Discontinued Operation
351,388
351,388
365,352
373,773
196,273
Normalized Income
351,388
351,388
365,352
303,568.32
196,273
Interest Income
39,372
39,372
41,532
7,963
107
Interest Expense
14,924
14,924
15,801
5,386
1,132
Net Interest Income
24,448
24,448
25,731
2,577
-1,025
EBIT
462,743
462,743
484,635
452,999
253,844
EBITDA
539,438
539,438
509,916
476,889
281,085
Reconciled Cost of Revenue
391,975
391,975
346,316
302,028
202,161
Reconciled Depreciation
76,695
76,695
25,281
23,890
27,241
Net Income from Continuing Operation Net Minority Interest
351,388
351,388
365,352
373,773
196,273
Total Unusual Items Excluding Goodwill
--
--
-14,992
83,577
0
Total Unusual Items
--
--
-14,992
83,577
0
Normalized EBITDA
539,438
539,438
509,916
393,312
281,085
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
13,372.32
0
12/31/2021 - 5/29/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MJ.CN Maven Brands Inc.
0.0200
0.00%
 
NMV.F Captor Capital Corp.
0.2940
0.00%
 
VIBEF Vibe Growth Corporation
0.0460
0.00%
 
RAMM.CN RAMM Pharma Corp.
0.0100
0.00%
 
CNADF CanadaBis Capital Inc.
0.0625
0.00%
 
HLTRF HLS Therapeutics Inc.
3.2200
0.00%
 
MILFF 1CM Inc.
0.1942
0.00%
 
MJRX.CN Global Health Clinics Ltd.
0.0100
0.00%
 
SEHCF Sweet Earth Holdings Corporation
0.4670
0.00%
 
XTXXF Adastra Holdings Ltd.
0.0378
0.00%